Nexus Surgical & Med
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
Nexus Surgical and Medicare appointed Anish More as managing director for three years, subject to shareholder approval, after Ram Swaroop Joshi resigned from the post with effect from 2 September 2026. Joshi remained a promoter non-executive director, while the board also appointed Ashish Durgaprasad Mishra as an independent director, reappointed Neha Kailash Bhageria for a second five-year term and reconstituted its committees.
Powered by Tijori
Nexus Surgical and Medicare appointed Anish More as managing director for three years, subject to shareholder approval, after Ram Swaroop Joshi resigned from the post with effect from 2 September 2026. Joshi remained a promoter non-executive director, while the board also appointed Ashish Durgaprasad Mishra as an independent director, reappointed Neha Kailash Bhageria for a second five-year term and reconstituted its committees.
Powered by Tijori
Sept 2 (Reuters) - Nexus Surgical and Medicare Ltd NEXU.BO:
RAM SWAROOP JOSHI RESIGNS AS MANAGING DIRECTOR
APPOINTS ANISH MORE AS MANAGING DIRECTOR
Further company coverage: NEXU.BO
(([email protected];))
Sept 2 (Reuters) - Nexus Surgical and Medicare Ltd NEXU.BO:
RAM SWAROOP JOSHI RESIGNS AS MANAGING DIRECTOR
APPOINTS ANISH MORE AS MANAGING DIRECTOR
Further company coverage: NEXU.BO
(([email protected];))
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Nexus Surgical & Med do?
Nexus Surgical and Medicare Limited, a public limited company in India, is listed on the Bombay Stock Exchange. It is primarily engaged in the trading of medical essentials.
Who are the competitors of Nexus Surgical & Med?
Nexus Surgical & Med major competitors are Gilada Finance & Inv, Cil Securities, DJS Stock & Shares, Gajanan Sec. Service, Comfort Commotrade, KBS India, Fruition Venture. Market Cap of Nexus Surgical & Med is ₹18 Crs. While the median market cap of its peers are ₹16 Crs.
Is Nexus Surgical & Med financially stable compared to its competitors?
Nexus Surgical & Med seems to be less financially stable compared to its competitors. Altman Z score of Nexus Surgical & Med is 8.28 and is ranked 4 out of its 8 competitors.
Does Nexus Surgical & Med pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Nexus Surgical & Med latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Nexus Surgical & Med allocated its funds?
Companies resources are allocated to majorly unproductive assets like Accounts Receivable
How strong is Nexus Surgical & Med balance sheet?
Balance sheet of Nexus Surgical & Med is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Nexus Surgical & Med improving?
Yes, profit is increasing. The profit of Nexus Surgical & Med is ₹0.79 Crs for TTM, ₹0.5 Crs for Mar 2025 and ₹0.21 Crs for Mar 2024.
Is the debt of Nexus Surgical & Med increasing or decreasing?
Yes, The net debt of Nexus Surgical & Med is increasing. Latest net debt of Nexus Surgical & Med is -₹0.5 Crs as of Mar-26. This is greater than Mar-25 when it was -₹0.66 Crs.
Is Nexus Surgical & Med stock expensive?
Nexus Surgical & Med is not expensive. Latest PE of Nexus Surgical & Med is 23.01, while 3 year average PE is 33.21. Also latest EV/EBITDA of Nexus Surgical & Med is 17.43 while 3yr average is 29.87.
Has the share price of Nexus Surgical & Med grown faster than its competition?
Nexus Surgical & Med has given lower returns compared to its competitors. Nexus Surgical & Med has grown at ~-4.54% over the last 10yrs while peers have grown at a median rate of 16.77%
Is the promoter bullish about Nexus Surgical & Med?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Nexus Surgical & Med is 18.73% and last quarter promoter holding is 18.73%.
Are mutual funds buying/selling Nexus Surgical & Med?
There is Insufficient data to gauge this.